PRODUCT CLASSIFICATION
Glycoprotein Cytokine
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Drogsan
WAREHOUSE
International Warehouse 2
ACTIVE INGREDIENT
Erythropoietin
Introducing Dropoetin, a vital solution prescribed for managing anemia associated with chronic kidney failure in both pediatric and adult patients undergoing hemodialysis and peritoneal dialysis. This powerful medication is also recommended for adults with renal insufficiency experiencing severe anemia symptoms, even before they start dialysis.
Moreover, Dropoetin plays a crucial role in addressing anemia and decreasing the need for blood transfusions in adult cancer patients (excluding those with myeloid malignancies) undergoing chemotherapy. It is also beneficial for adult patients with HIV receiving zidovudine treatment, specifically those whose endogenous Dropoetin levels are at or below 500 mU/ml.
For adults, Dropoetin supports autologous blood collection in predeposit programs, significantly reducing the risk of requiring allogeneic blood transfusions in patients with moderate anemia (hematocrit levels of 33-39%, hemoglobin levels between 10-13 g/dL, and no iron deficiency) scheduled for major elective surgeries that may demand more blood than can be collected through autologous methods without Dropoetin. This treatment is particularly recommended when alternative blood conservation strategies are insufficient for procedures anticipated to require four or more units for females or five or more units for males.
Dropoetin is also indicated to enhance red blood cell production during the perioperative period, minimizing the need for allogeneic blood transfusions and addressing postoperative anemia in adult patients without iron deficiency undergoing major elective orthopedic surgeries. Its use is advised solely for those with moderate anemia (e.g., hemoglobin levels of 10-13 g/dL) lacking access to an autologous donation program and who are expected to experience moderate blood loss (900 to 1800 ml).
Additionally, Dropoetin serves as a treatment option for anemia in patients with Low or Intermediate-1 risk Myelodysplastic Syndrome (MDS), targeting candidates with a hemoglobin level below 10 g/dL.
How to Use Dropoetin
Administer Dropoetin exactly as prescribed by your healthcare provider, and refer to the medication label for specific dosage guidelines. This product comes with a Medication Guide; ensure you read it thoroughly and consult it each time you refill your prescription.
Typically, Dropoetin is administered via injection at a healthcare facility. If you are trained to self-administer Dropoetin at home, a healthcare professional will provide detailed instructions. Be sure to follow the administration techniques you've been taught and reach out to your healthcare provider with any questions.
When preparing your dose, adhere to the established protocols to avoid contamination. Refrain from touching the rubber stopper of the vial or the syringe needle with your fingers. Double-check that you have the correct dosage before injection.
Do not shake Dropoetin, and avoid using it if it has been shaken or frozen. Never dilute Dropoetin or mix it with other solutions unless directed by your doctor.
If using a single-dose vial, dispose of any remaining medication post-administration. For questions regarding single-dose vials, consult your doctor, pharmacist, or healthcare provider. Also, avoid using Dropoetin if it appears cloudy, discolored, contains particles, or if the vial is cracked or damaged.
Store Dropoetin, along with syringes and needles, out of reach of children and pets. Always discard used needles and syringes properly, and inquire with your healthcare provider about safe disposal methods while adhering to local regulations.
Continue using Dropoetin even if you feel well, and do not skip any doses. If you miss a dose, contact your doctor promptly.
For any inquiries about using Dropoetin, don?t hesitate to consult your healthcare provider.
Potential Side Effects of Dropoetin
Please be aware of the following serious adverse reactions, which are detailed in other sections of the label: